8-K: NextNRG Secures $3 Million Loan, Pledges Millions of Shares as Collateral

NextNRG, Inc. has secured a $3 million loan from two accredited investors, with interest paid in common stock and additional shares pledged as collateral, under terms including bi-weekly payments and a "bleed out" provision for share sales upon default.

Summary

• NextNRG, Inc. entered into loan agreements with two accredited investors on June 27, 2025, securing a total of $3,000,000 ($1,500,000 from each lender).
• Interest for the full term of the loans, totaling $1,350,000, was paid upfront through the issuance of 450,000 shares of common stock, valued at $3.00 per share.
• The company pledged an aggregate of 5,800,000 shares of common stock (2,900,000 shares per lender) as collateral for the loans. These shares are held in a reserve account by the company's transfer agent, ClearTrust, LLC.
• Bi-weekly payments of $75,000 are scheduled to begin on July 10, 2025.
• The loans mature on July 14, 2027, but the principal amount is payable upon demand by the lenders on or after December 15, 2026.
• In the event of a default, lenders can sell the pledged shares, but are restricted to selling no more than 20% of the average daily trading volume of NextNRG's common stock on any given trading day ("Bleed Out" provision).
• The issuance and sale of these shares are registered under the company's effective shelf registration statement on Form S-3 (File No. 333-268960).

Sentiment

Score: 3

Explanation: While the company secured financing, the terms involve significant equity dilution for interest payments and substantial shares pledged as collateral, indicating potentially high cost of capital and future dilution risk. The early callable feature also adds to financial uncertainty.

Positives

• Secured $3,000,000 in financing from accredited investors.
• Interest for the full loan term is paid upfront, simplifying future cash flow management for interest payments.
• The "Bleed Out" provision limits the daily volume of shares that can be sold by lenders upon default, potentially mitigating immediate downward pressure on the stock price.

Negatives

• Significant dilution from the issuance of 450,000 shares for interest and the pledging of 5,800,000 shares as collateral, which could be sold upon default.
• The loan principal becomes payable upon demand by lenders as early as December 15, 2026, introducing refinancing risk.
• The interest payment in shares at a fixed price of $3.00 per share means the company effectively paid a high interest rate if the stock price is lower than $3.00 at the time of issuance, or if the stock price declines significantly.
• The "Bleed Out" provision, while limiting daily sales, still allows for substantial potential future dilution and downward pressure on the stock over time if a default occurs.

Risks

• Dilution Risk: The issuance of 450,000 shares for interest and the potential sale of 5,800,000 pledged shares upon default could significantly dilute existing shareholders.
• Refinancing Risk: The loan principal is payable upon demand by lenders on or after December 15, 2026, which is earlier than the stated maturity date of July 14, 2027, potentially requiring the company to secure new financing under unfavorable terms.
• Stock Price Volatility: The "Bleed Out" provision, while limiting daily sales, still allows for a sustained selling pressure on the stock if a default occurs, potentially leading to prolonged stock price depreciation.
• Default Risk: Failure to make bi-weekly payments of $75,000 or comply with other loan covenants could trigger an Event of Default, leading to the transfer and sale of pledged shares.
• Market Overhang: The large number of shares pledged as collateral (5,800,000) creates a significant market overhang, which could depress the stock price even without a default, as investors anticipate potential future sales.

Future Outlook

The company is committed to making bi-weekly payments of $75,000 starting July 10, 2025, with the loan principal becoming callable by lenders on or after December 15, 2026, and a final maturity date of July 14, 2027. The terms allow for the sale of pledged shares upon default, subject to a 20% average daily volume limit, indicating a structured approach to managing potential future liabilities.

Management Comments

• NextNRG, Inc. (the Company) entered into loan agreements (each a Loan Agreement), an addendum to each of the Loan Agreement (the Loan Agreements, as amended, the Loans Agreements) with two accredited investors (each a Lender and together the Lenders).
• Pursuant to the Loans Agreements, the Company received from each of the Lenders a loan in the amount of $1,500,000 and agreed to pay the full amount of interest due on the loans on the execution date of the Loan Agreement in the form of shares of common stock, par value $0.0001 per share (the Interest Shares) at a price of $3.00 per share.
• The aggregate amount of interest due on the loans for the full term of the loans is $1,350,000 and the Company will issue an aggregate amount of 450,000 Interest Shares to the Lenders.
• In addition, pursuant to the Loans Agreement and the Pledge and Security Agreements, the Company agreed to pledge an aggregate amount of 5,800,000 shares of Common Stock to secure the loans (the Pledged Shares and, together with the Interest Shares, the Shares).
• In the event of default on any of the loans, the Company will issue the Lender that the Company has defaulted on its loan 2,900,000 Pledged Shares.
• Each of the Lenders will then sell the number of Pledged Shares needed to be sold in order to cover the outstanding amount of its loan, and will transfer to the Company, for no payment from the Company, all the remaining Pledged Shares that were not sold by it.
• The sale and issuance of the Shares under the Loans Agreement and Pledge and Security Agreement will be made pursuant to the Companys shelf registration statement on Form S-3 (File No. 333-268960), which was filed with the Securities and Exchange Commission (the Commission) on December 22, 2022, and declared effective on January 3, 2023, and a prospectus supplement to the base prospectus forming a part of such registration statement, which was filed by the Company with the Commission on June 30, 2025.

Industry Context

This financing arrangement, involving a significant loan secured by common stock and interest paid in shares, is characteristic of companies seeking capital without incurring immediate cash interest payments, often seen in growth-stage or smaller-cap companies. The "Bleed Out" provision is a common mechanism in such equity-linked debt instruments to manage market impact upon potential share sales. The use of a shelf registration statement indicates a pre-existing plan for raising capital through equity.

Comparison to Industry Standards

• The use of common stock for interest payments and as collateral is a less conventional financing method compared to traditional bank loans or corporate bonds, often indicating a company's limited access to conventional debt markets or a preference to conserve cash.
• The $3.00 per share valuation for interest and collateral shares should be compared to the company's current market trading price to assess the effective cost of capital and potential immediate dilution. If the market price is significantly lower, the cost of this financing is effectively higher.
• The "Bleed Out" provision (20% of average daily volume) is a standard protective measure for companies in such agreements, aiming to prevent a rapid collapse of the stock price if collateral shares are liquidated. However, the effectiveness depends on the company's average daily trading volume. For low-volume stocks, even 20% can represent substantial selling pressure over time.
• The ability for lenders to demand payment on or after December 15, 2026, introduces a shorter-term liquidity risk compared to a fixed maturity date, which is a less favorable term than typically found in standard corporate debt.

Stakeholder Impact

• Shareholders: Face significant potential dilution from the issuance of shares for interest and the large number of shares pledged as collateral, which could be sold upon default. This could depress share price.
• Creditors (Lenders): Have secured their loans with a substantial number of common shares and receive interest upfront in shares, providing a strong position.
• Employees: No direct impact mentioned, but financial stability or instability can indirectly affect employees.
• Customers/Suppliers: No direct impact mentioned.

Next Steps

• Make bi-weekly loan payments of $75,000 starting July 10, 2025.
• Manage the loan obligations to avoid an Event of Default, which would trigger the transfer and potential sale of pledged shares.
• Monitor the loan's callable date of December 15, 2026, and prepare for potential early repayment or refinancing.
• Ensure compliance with the "Bleed Out" provision if collateral shares need to be sold by lenders.

Key Dates

Recommendation

Keywords

NextNRG, Loan Agreement, Pledge Agreement, Security Agreement, Collateral, Common Stock, Dilution, Debt Financing, SEC Filing, 8-K, Shelf Registration, S-3, Accredited Investors, Interest Shares, Pledged Shares, Bleed Out, Corporate Finance, Risk Management, Capital Raise